Enveric Biosciences, Inc. (ENVB)
ENVB Stock Price Chart
Explore Enveric Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze ENVB price movements and trends.
ENVB Company Profile
Discover essential business fundamentals and corporate details for Enveric Biosciences, Inc. (ENVB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 May 2015
Employees
5.00
Website
https://www.enveric.comCEO
Joseph Edward Tucker
Description
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
ENVB Financial Timeline
Browse a chronological timeline of Enveric Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Aug 2026
Earnings released on 15 May 2026
EPS came in at -$1.08 .
Earnings released on 27 Mar 2026
EPS came in at $0.85 surpassing the estimated -$55.80 by +101.52%.
Earnings released on 14 Nov 2025
EPS came in at -$10.81 surpassing the estimated -$63.00 by +82.84%.
Stock split effective on 28 Oct 2025
Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2025
EPS came in at -$11.64 surpassing the estimated -$63.00 by +81.52%.
Earnings released on 14 May 2025
EPS came in at -$1.22 surpassing the estimated -$6.00 by +79.67%.
Earnings released on 31 Mar 2025
EPS came in at -$21.89 falling short of the estimated -$3.45 by -534.49%, while revenue for the quarter reached $340.38k .
Earnings released on 14 Nov 2024
EPS came in at -$3.60 surpassing the estimated -$7.80 by +53.85%.
Earnings released on 12 Aug 2024
EPS came in at -$3.75 surpassing the estimated -$8.25 by +54.55%.
Earnings released on 14 May 2024
EPS came in at -$9.15 matching the estimated -$9.15.
Earnings released on 25 Mar 2024
EPS came in at -$21.89 surpassing the estimated -$23.24 by +5.81%, while revenue for the quarter reached $647.09k .
Earnings released on 13 Nov 2023
EPS came in at -$19.49 surpassing the estimated -$28.94 by +32.65%.
Earnings released on 14 Aug 2023
EPS came in at -$45.58 falling short of the estimated -$0.65 by -6.91k%.
Earnings released on 8 Jun 2023
EPS came in at -$6.76 .
Earnings released on 15 May 2023
EPS came in at -$33.28 surpassing the estimated -$33.45 by +0.51%.
Earnings released on 14 Nov 2022
EPS came in at -$21.89 falling short of the estimated -$4.00 by -447.25%.
Earnings released on 12 Aug 2022
EPS came in at -$40.93 falling short of the estimated -$3.83 by -968.67%.
Stock split effective on 15 Jul 2022
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 May 2022
EPS came in at -$82.46 falling short of the estimated -$6.00 by -1.27k%.
Earnings released on 31 Mar 2022
EPS came in at -$104.95 falling short of the estimated -$8.00 by -1.21k%.
Earnings released on 15 Nov 2021
EPS came in at -$6.00 surpassing the estimated -$8.00 by +25.00%.
Earnings released on 13 Aug 2021
EPS came in at -$2.00 surpassing the estimated -$8.75 by +77.14%.
ENVB Stock Performance
Access detailed ENVB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
